Clinical Trials · NCT01841359

Pramlintide (Symlin) for the Treatment of Hypoglycemia Following Gastric Bypass Surgery

CompletedPhase 4Pramlintide (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
Joslin Diabetes Center
Enrollment
22
Start date
Feb 2010
Locations
1 site, United States
Primary endpoint
Plasma Glucose Levels in Response to Mixed Meal Testing - Area Under the Curve for Plasma Glucose
View Pramlintide compound reference